Filing Details
- Accession Number:
- 0001179110-20-005520
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-06 16:02:49
- Reporting Period:
- 2020-05-04
- Accepted Time:
- 2020-05-06 16:02:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1017832 | P Martin Sutter | 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2020-05-04 | 12,000 | $9.99 | 200,939 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2020-05-04 | 2,290 | $178.44 | 198,649 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2020-05-04 | 1,400 | $179.35 | 197,249 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2020-05-04 | 1,100 | $180.39 | 196,149 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2020-05-04 | 6,584 | $181.46 | 189,565 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2020-05-04 | 626 | $182.14 | 188,939 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-05-04 | 12,000 | $0.00 | 12,000 | $9.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-08-10 | 2020-08-11 | No | 4 | M | Direct |
Footnotes
- Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- Exercise of stock options in advance of the expiration of ten year contractual term of the underlying awards.
- Sale of common stock solely for the payment of tax liability associated with the exercise of options.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $177.9600 and $178.8900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $178.9600 and $179.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $180.0000 and $180.9050. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $180.9900 and $181.9300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $181.9900 and $182.1900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
